Xiaohui Guo

Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials

F. Lauand, Lingyu Li, Wenying Yang, 2024, Diabetes, obesity & metabolism.